Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening with GenoType® MTBDRplus shortens the time to MDR-TB treatment initiation but does not change outcomes.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease - 1 Dec 2023

Mendoza-Ticona A, Mitnick C D, Obregón G, Alarcón V

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Genotype
Share to Isoniazid
Share to Microbial Sensitivity Tests

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Mycobacterium tuberculosis

Share to Tuberculosis, Multidrug-Resistant

Source

Identifiers

PMID: 38042965
DOI: 10.5588/ijtld.23.0096

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening with GenoType® MTBDRplus shortens the time to MDR-TB treatment initiation but does not change outcomes.PMID 38042965Read ↗

Implementation of genotype MTBDRplus reduces time to multidrug-resistant tuberculosis therapy initiation in South Africa.Semantic proximity Read ↗

Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal studySemantic proximity Read ↗

Performance of the GenoType MTBDRplus assay directly on sputum specimens from Brazilian patients with tuberculosis treatment failure or relapse.Semantic proximity Read ↗

GenoType® MTBDRplus compared with conventional drug-susceptibility testing of Mycobacterium tuberculosis in a low-resistance locale.Semantic proximity Read ↗

Performance of the genotype MTBDR assay for molecular detection of multidrug-resistant strains of Mycobacterium tuberculosis.Semantic proximity Read ↗

A comparison of the Xpert(®) MTB/RIF and GenoType(®) MTBDRplus assays in Georgia.Semantic proximity Read ↗

Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline.Semantic proximity Read ↗

The diagnostic performance of the GenoType MTBDRplus version 2 line probe assay is equivalent to that of the Xpert MTB/RIF assay.Semantic proximity Read ↗

Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa.Semantic proximity Read ↗

Molecular drug susceptibility testing in the Netherlands: performance of the MTBDRplus and MTBDRsl assays.Semantic proximity Read ↗

Evaluation of the GenoType(®) MTBDRplus line probe assay on sputum-positive samples in routine settings in China.Semantic proximity Read ↗

Xpert MTB/RIF<sup>®</sup>cycle threshold as a marker of TB disease severity; Implications for TB treatment stratificationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.